{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T09:52:54Z","timestamp":1758361974256,"version":"3.44.0"},"reference-count":78,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T00:00:00Z","timestamp":1749686400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100010761","name":"Syngenta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010761","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Toxicogenomics-based approaches are powerful tools for investigating the mode of action and human relevance of chemical-induced effects in animal toxicity studies, thus supporting human risk assessment and regulatory decisions. Here, we incorporated transcriptomics and metabolomics into a mode of action assessment of male mouse liver tumors observed following 80-week dietary exposure to cyclobutrifluram, a novel complex II succinate dehydrogenase inhibitor agrochemical. The assessment was conducted using the framework developed by the International Programme on Chemical Safety (IPCS) and the International Life Sciences Institute (ILSI), based on activation of the nuclear constitutive androstane receptor (CAR) and subsequent downstream events that have been established as human non-relevant. Cyclobutrifluram was shown to activate rat, mouse, and human CAR in in vitro transactivation assays. Dietary administration of cyclobutrifluram in male mice was associated with time- and\/or dose-dependent liver weight increases, centrilobular hepatocellular hypertrophy, induction of CAR-related liver enzyme activity, specifically CYP2B and CYP3A, and hepatocellular proliferation. Transcriptomics analysis of mouse liver identified cyclobutrifluram-induced gene expression profiles consistent with CAR activation, based on published signatures and similarity to the reference CAR inducer phenobarbital. Metabolomics analysis of mouse plasma and liver further indicated that cyclobutrifluram induced similar biochemical changes as phenobarbital, with no evidence of any additional activity. Overall, this work demonstrates how toxicogenomics can provide valuable weight of evidence to identify the mode of action for chemical-induced rodent liver tumors and to exclude alternative modes of action.<\/jats:p>","DOI":"10.1093\/toxsci\/kfaf085","type":"journal-article","created":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T07:49:32Z","timestamp":1749628172000},"page":"238-255","source":"Crossref","is-referenced-by-count":0,"title":["Leveraging toxicogenomics in a weight of evidence approach to demonstrate a CAR-mediated mode of action for cyclobutrifluram-related mouse liver tumors"],"prefix":"10.1093","volume":"207","author":[{"given":"Fang","family":"Zhang","sequence":"first","affiliation":[{"name":"Syngenta Ltd, Jealott\u2019s Hill International Research Centre , Bracknell, Berkshire RG42 6EY,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caleb C","family":"Lord","sequence":"additional","affiliation":[{"name":"Syngenta Crop Protection, LLC , Greensboro , NC 27419-8300,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aniko","family":"Kende","sequence":"additional","affiliation":[{"name":"Syngenta Ltd, Jealott\u2019s Hill International Research Centre , Bracknell, Berkshire RG42 6EY,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E","family":"Cowie","sequence":"additional","affiliation":[{"name":"Syngenta Ltd, Jealott\u2019s Hill International Research Centre , Bracknell, Berkshire RG42 6EY,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2359-6436","authenticated-orcid":false,"given":"Liam B","family":"Doonan","sequence":"additional","affiliation":[{"name":"Syngenta Ltd, Jealott\u2019s Hill International Research Centre , Bracknell, Berkshire RG42 6EY,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathryn A","family":"Bailey","sequence":"additional","affiliation":[{"name":"Syngenta Crop Protection, LLC , Greensboro , NC 27419-8300,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth F","family":"McInnes","sequence":"additional","affiliation":[{"name":"Syngenta Ltd, Jealott\u2019s Hill International Research Centre , Bracknell, Berkshire RG42 6EY,","place":["United Kingdom"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Hofstra","sequence":"additional","affiliation":[{"name":"Syngenta Canada Inc. , Guelph , ON N1G 4Z3,","place":["Canada"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,6,12]]},"reference":[{"key":"2025091914021034600_kfaf085-B1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1186\/1471-2407-9-187","article-title":"Cytochrome P450 CYP1A1: wider roles in cancer progression and prevention","volume":"9","author":"Androutsopoulos","year":"2009","journal-title":"BMC Cancer"},{"key":"2025091914021034600_kfaf085-B2","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.yrtph.2015.06.015","article-title":"The adverse outcome pathway for rodent liver tumor promotion by sustained activation of the aryl hydrocarbon receptor","volume":"73","author":"Becker","year":"2015","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025091914021034600_kfaf085-B3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B Methodol"},{"key":"2025091914021034600_kfaf085-B4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1080\/10408440600977677","article-title":"IPCS framework for analyzing the relevance of a cancer mode of action for humans","volume":"36","author":"Boobis","year":"2006","journal-title":"Crit Rev Toxicol"},{"key":"2025091914021034600_kfaf085-B5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/0006-2952(94)90363-8","article-title":"Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver","volume":"48","author":"Burke","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"2025091914021034600_kfaf085-B6","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1289\/ehp.971051196","article-title":"The significance of mouse liver tumor formation for carcinogenic risk assessment: results and conclusions from a survey of ten years of testing by the agrochemical industry","volume":"105","author":"Carmichael","year":"1997","journal-title":"Environ Health Perspect"},{"key":"2025091914021034600_kfaf085-B7","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.toxlet.2017.05.006","article-title":"Mode of action and human relevance of THF-induced mouse liver tumors","volume":"276","author":"Choi","year":"2017","journal-title":"Toxicol Lett"},{"key":"2025091914021034600_kfaf085-B8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1177\/0192623310363813","article-title":"Evaluation of possible carcinogenic risk to humans based on liver tumors in rodent assays: the two-year bioassay is no longer necessary","volume":"38","author":"Cohen","year":"2010","journal-title":"Toxicol Pathol"},{"key":"2025091914021034600_kfaf085-B9","doi-asserted-by":"crossref","first-page":"1394584","DOI":"10.3389\/fonc.2024.1394584","article-title":"Cell proliferation and carcinogenesis: an approach to screening for potential human carcinogens","volume":"14","author":"Cohen","year":"2024","journal-title":"Front Oncol"},{"key":"2025091914021034600_kfaf085-B10","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.20883","article-title":"Gadd45beta is induced through a CAR-dependent, TNF-independent pathway in murine liver hyperplasia","volume":"42","author":"Columbano","year":"2005","journal-title":"Hepatology"},{"key":"2025091914021034600_kfaf085-B11","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0014-5793(98)00246-4","article-title":"Phenobarbital induces cytochrome P4501A2 hnRNA, mRNA and protein in the liver of C57BL\/6J wild type and aryl hydrocarbon receptor knock-out mice","volume":"425","author":"Corcos","year":"1998","journal-title":"FEBS Lett"},{"key":"2025091914021034600_kfaf085-B12","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/carcin\/bgq028","article-title":"The aryl hydrocarbon receptor (AhR) in the regulation of cell-cell contact and tumor growth","volume":"31","author":"Dietrich","year":"2010","journal-title":"Carcinogenesis"},{"key":"2025091914021034600_kfaf085-B13","doi-asserted-by":"crossref","first-page":"64","DOI":"10.3109\/10408444.2013.835786","article-title":"Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: a case study with phenobarbital as a model constitutive androstane receptor (CAR) activator","volume":"44","author":"Elcombe","year":"2014","journal-title":"Crit Rev Toxicol"},{"key":"2025091914021034600_kfaf085-B14","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/ijc.24545","article-title":"Epidemiologic evaluation of pharmaceuticals with limited evidence of carcinogenicity","volume":"125","author":"Friedman","year":"2009","journal-title":"Int J Cancer"},{"key":"2025091914021034600_kfaf085-B15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/me.2007-0121","article-title":"Genome-wide identification of estrogen receptor alpha-binding sites in mouse liver","volume":"22","author":"Gao","year":"2008","journal-title":"Mol Endocrinol"},{"key":"2025091914021034600_kfaf085-B16","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.4049\/jimmunol.133.4.1710","article-title":"Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67","volume":"133","author":"Gerdes","year":"1984","journal-title":"J Immunol"},{"key":"2025091914021034600_kfaf085-B17","first-page":"e200908","article-title":"The use of NAMs and omics data in risk assessment","volume":"20","author":"German Federal Institute for Risk Assessment (BfR), Berlin, Germany","year":"2022","journal-title":"EFSA J"},{"key":"2025091914021034600_kfaf085-B18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/toxsci\/kfu014","article-title":"Dose-response modeling of early molecular and cellular key events in the CAR-mediated hepatocarcinogenesis pathway","volume":"138","author":"Geter","year":"2014","journal-title":"Toxicol Sci"},{"key":"2025091914021034600_kfaf085-B19","doi-asserted-by":"crossref","first-page":"153828","DOI":"10.1016\/j.tox.2024.153828","article-title":"Mode of action analysis for fluxapyroxad-induced rat liver tumour formation:evidence for activation of the constitutive androstane receptor and assessment of human relevance","volume":"505","author":"Goettel","year":"2024","journal-title":"Toxicology"},{"key":"2025091914021034600_kfaf085-B20","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2174\/138920008783884696","article-title":"Toxicogenomics","volume":"9","author":"Gomase","year":"2008","journal-title":"Curr Drug Metab"},{"key":"2025091914021034600_kfaf085-B21","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1039\/c8tx00004b","article-title":"Goodbye to the bioassay","volume":"7","author":"Goodman","year":"2018","journal-title":"Toxicol Res (Camb)"},{"key":"2025091914021034600_kfaf085-B22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1177\/0192623312448935","article-title":"Liver hypertrophy: a review of adaptive (adverse and non-adverse) changes\u2014conclusions from the 3rd International ESTP Expert Workshop","volume":"40","author":"Hall","year":"2012","journal-title":"Toxicol Pathol"},{"key":"2025091914021034600_kfaf085-B23","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0272-0590(83)80148-1","article-title":"A reexamination of false-positive rates for carcinogenesis studies","volume":"3","author":"Haseman","year":"1983","journal-title":"Fundam Appl Toxicol"},{"key":"2025091914021034600_kfaf085-B24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1093\/toxsci\/kfj001","article-title":"Mode of action in relevance of rodent liver tumors to human cancer risk","volume":"89","author":"Holsapple","year":"2006","journal-title":"Toxicol Sci"},{"key":"2025091914021034600_kfaf085-B25","doi-asserted-by":"crossref","first-page":"5652","DOI":"10.1128\/MCB.18.10.5652","article-title":"The nuclear orphan receptor CAR-retinoid X receptor heterodimer activates the phenobarbital-responsive enhancer module of the CYP2B gene","volume":"18","author":"Honkakoski","year":"1998","journal-title":"Mol Cell Biol"},{"key":"2025091914021034600_kfaf085-B26","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1124\/mol.106.032748","article-title":"Induction of cyp1a1 is a nonspecific biomarker of aryl hydrocarbon receptor activation: results of large scale screening of pharmaceuticals and toxicants in vivo and in vitro","volume":"71","author":"Hu","year":"2007","journal-title":"Mol Pharmacol"},{"key":"2025091914021034600_kfaf085-B27","doi-asserted-by":"crossref","first-page":"4156","DOI":"10.1073\/pnas.0630614100","article-title":"Induction of bilirubin clearance by the constitutive androstane receptor (CAR)","volume":"100","author":"Huang","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025091914021034600_kfaf085-B28","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/me.2004-0520","article-title":"Xenobiotic stress induces hepatomegaly and liver tumors via the nuclear receptor constitutive androstane receptor","volume":"19","author":"Huang","year":"2005","journal-title":"Mol Endocrinol"},{"key":"2025091914021034600_kfaf085-B29","first-page":"100930","volume-title":"JHEP Rep","author":"Huillet","year":"2024"},{"key":"2025091914021034600_kfaf085-B30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/41.1.8093255","article-title":"Phenobarbital-induced hepatocellular proliferation: anti-bromodeoxyuridine and anti-proliferating cell nuclear antigen immunocytochemistry","volume":"41","author":"Jones","year":"1993","journal-title":"J Histochem Cytochem"},{"key":"2025091914021034600_kfaf085-B31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.toxlet.2023.04.008","article-title":"Mode of action hypothesis testing in chemical safety assessments using metabolomics as supporting evidence: phenobarbital and cyclobutrifluram metabolomics profile comparison","volume":"382","author":"Kende","year":"2023","journal-title":"Toxicol Lett"},{"key":"2025091914021034600_kfaf085-B32","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1080\/713608372","article-title":"PPARalpha agonist-induced rodent tumors: modes of action and human relevance","volume":"33","author":"Klaunig","year":"2003","journal-title":"Crit Rev Toxicol"},{"key":"2025091914021034600_kfaf085-B33","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/toxsci\/kfn179","article-title":"Induction of hepatic glutathione S-transferases in male mice by prototypes of various classes of microsomal enzyme inducers","volume":"106","author":"Knight","year":"2008","journal-title":"Toxicol Sci"},{"issue":":","key":"2025091914021034600_kfaf085-B34","doi-asserted-by":"crossref","first-page":"e13066","DOI":"10.1371\/journal.pone.0013066","article-title":"Ontology-based meta-analysis of global collections of high-throughput public data","volume":"5","author":"Kupershmidt","year":"2010","journal-title":"PLoS One"},{"key":"2025091914021034600_kfaf085-B35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CEJ.0b013e32836014c8","article-title":"A review of epidemiological data on epilepsy, phenobarbital, and risk of liver cancer","volume":"23","author":"La Vecchia","year":"2014","journal-title":"Eur J Cancer Prev"},{"key":"2025091914021034600_kfaf085-B36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/00498250903098184","article-title":"Species differences in the hepatic effects of inducers of CYP2B and CYP4A subfamily forms: relationship to rodent liver tumour formation","volume":"39","author":"Lake","year":"2009","journal-title":"Xenobiotica"},{"key":"2025091914021034600_kfaf085-B37","doi-asserted-by":"crossref","first-page":"104655","DOI":"10.1016\/j.yrtph.2020.104655","article-title":"Short-term toxicogenomics as an alternative approach to chronic in vivo studies for derivation of points of departure: a case study in the rat with a triazole fungicide","volume":"113","author":"LaRocca","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025091914021034600_kfaf085-B38","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.taap.2013.04.009","article-title":"An integrated approach for prospectively investigating a mode-of-action for rodent liver effects","volume":"270","author":"LeBaron","year":"2013","journal-title":"Toxicol Appl Pharmacol"},{"key":"2025091914021034600_kfaf085-B39","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0009-2797(90)90075-X","article-title":"Induction of hepatic cytochrome P-450 mediated alkoxyresorufin O-dealkylase activities in different species by prototype P-450 inducers","volume":"75","author":"Lubet","year":"1990","journal-title":"Chem Biol Interact"},{"key":"2025091914021034600_kfaf085-B40","doi-asserted-by":"crossref","first-page":"104789","DOI":"10.1016\/j.yrtph.2020.104789","article-title":"A comprehensive view on mechanistic approaches for cancer risk assessment of non-genotoxic agrochemicals","volume":"118","author":"Luijten","year":"2020","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025091914021034600_kfaf085-B41","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.62.3.638","article-title":"Nuclear pregnane x receptor and constitutive androstane receptor regulate overlapping but distinct sets of genes involved in xenobiotic detoxification","volume":"62","author":"Maglich","year":"2002","journal-title":"Mol Pharmacol"},{"key":"2025091914021034600_kfaf085-B42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jat.2949","article-title":"New developments in the evolution and application of the WHO\/IPCS framework on mode of action\/species concordance analysis","volume":"34","author":"Meek","year":"2014","journal-title":"J Appl Toxicol"},{"key":"2025091914021034600_kfaf085-B43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1080\/713608373","article-title":"A framework for human relevance analysis of information on carcinogenic modes of action","volume":"33","author":"Meek","year":"2003","journal-title":"Crit Rev Toxicol"},{"key":"2025091914021034600_kfaf085-B44","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1016\/j.celrep.2018.06.110","article-title":"Ki67 is a graded rather than a binary marker of proliferation versus quiescence","volume":"24","author":"Miller","year":"2018","journal-title":"Cell Rep"},{"key":"2025091914021034600_kfaf085-B45","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/0006-2952(93)90504-P","article-title":"Methoxyresorufin and benzyloxyresorufin: substrates preferentially metabolized by cytochromes P4501A2 and 2B, respectively, in the rat and mouse","volume":"46","author":"Nerurkar","year":"1993","journal-title":"Biochem Pharmacol"},{"key":"2025091914021034600_kfaf085-B46","doi-asserted-by":"crossref","first-page":"8385","DOI":"10.1093\/nar\/gky692","article-title":"In vivo genome-wide binding interactions of mouse and human constitutive androstane receptors reveal novel gene targets","volume":"46","author":"Niu","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"2025091914021034600_kfaf085-B47","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1093\/toxsci\/kfr191","article-title":"Multi-species analyses of direct activators of the constitutive androstane receptor","volume":"123","author":"Omiecinski","year":"2011","journal-title":"Toxicol Sci"},{"key":"2025091914021034600_kfaf085-B48","doi-asserted-by":"crossref","first-page":"e002","DOI":"10.1621\/nrs.13002","article-title":"Identification of chemical modulators of the constitutive activated receptor (CAR) in a gene expression compendium","volume":"13","author":"Oshida","year":"2015","journal-title":"Nucl Recept Signal"},{"key":"2025091914021034600_kfaf085-B49","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.tox.2015.07.005","article-title":"Screening a mouse liver gene expression compendium identifies modulators of the aryl hydrocarbon receptor (AhR)","volume":"336","author":"Oshida","year":"2015","journal-title":"Toxicology"},{"key":"2025091914021034600_kfaf085-B50","doi-asserted-by":"crossref","first-page":"e0112655","DOI":"10.1371\/journal.pone.0112655","article-title":"Identification of modulators of the nuclear receptor peroxisome proliferator-activated receptor alpha (PPARalpha) in a mouse liver gene expression compendium","volume":"10","author":"Oshida","year":"2015","journal-title":"PLoS One"},{"key":"2025091914021034600_kfaf085-B51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.fct.2013.08.020","article-title":"Evaluation of the utility of the lifetime mouse bioassay in the identification of cancer hazards for humans","volume":"60","author":"Osimitz","year":"2013","journal-title":"Food Chem Toxicol"},{"key":"2025091914021034600_kfaf085-B52","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1080\/03602530600570081","article-title":"On the mechanism of hepatocarcinogenesis of benzodiazepines: evidence that diazepam and oxazepam are CYP2B inducers in rats, and both CYP2B and CYP4A inducers in mice","volume":"38","author":"Parkinson","year":"2006","journal-title":"Drug Metab Rev"},{"key":"2025091914021034600_kfaf085-B53","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/toxsci\/kfx281","article-title":"Sedaxane-use of nuclear receptor transactivation assays, toxicogenomics, and toxicokinetics as part of a mode of action framework for rodent liver tumors","volume":"162","author":"Peffer","year":"2018","journal-title":"Toxicol Sci"},{"key":"2025091914021034600_kfaf085-B54","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yrtph.2018.04.001","article-title":"Minimum datasets to establish a CAR-mediated mode of action for rodent liver tumors","volume":"96","author":"Peffer","year":"2018","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025091914021034600_kfaf085-B55","first-page":"311","article-title":"Guidelines for simple, sensitive significance tests for carcinogenic effects in long-term animal experiments","author":"Peto","year":"1980","journal-title":"IARC Monogr Eval Carcinog Risk Chem Hum Suppl"},{"key":"2025091914021034600_kfaf085-B56","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/hmg\/ddi227","article-title":"Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations","volume":"14","author":"Pollard","year":"2005","journal-title":"Hum Mol Genet"},{"key":"2025091914021034600_kfaf085-B57","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1210\/en.2004-1350","article-title":"Role of the constitutive androstane receptor in xenobiotic-induced thyroid hormone metabolism","volume":"146","author":"Qatanani","year":"2005","journal-title":"Endocrinology"},{"key":"2025091914021034600_kfaf085-B58","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res"},{"key":"2025091914021034600_kfaf085-B59","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res"},{"key":"2025091914021034600_kfaf085-B60","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/10408444.2014.986054","article-title":"Contribution of new technologies to characterization and prediction of adverse effects","volume":"45","author":"Rouquie","year":"2015","journal-title":"Crit Rev Toxicol"},{"key":"2025091914021034600_kfaf085-B61","doi-asserted-by":"crossref","first-page":"108082","DOI":"10.1016\/j.envint.2023.108082","article-title":"New approach methodologies in human regulatory toxicology\u2014not if, but how and when!","volume":"178","author":"Schmeisser","year":"2023","journal-title":"Environ Int"},{"key":"2025091914021034600_kfaf085-B62","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","author":"Selak","year":"2005","journal-title":"Cancer Cell"},{"key":"2025091914021034600_kfaf085-B63","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/toxsci\/kfad129","article-title":"Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation","volume":"198","author":"Shizu","year":"2024","journal-title":"Toxicol Sci"},{"key":"2025091914021034600_kfaf085-B64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/rtph.2001.1493","article-title":"IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis","volume":"34","author":"Sonich-Mullin","year":"2001","journal-title":"Regul Toxicol Pharmacol"},{"issue":":","key":"2025091914021034600_kfaf085-B65","doi-asserted-by":"crossref","first-page":"13246","DOI":"10.3390\/ijms241713246","article-title":"Increased cell proliferation as a key event in chemical carcinogenesis: Application in an integrated approach for the testing and assessment of non-genotoxic carcinogenesis","volume":"24","author":"Strupp","year":"2023","journal-title":"Int J Mol Sci"},{"key":"2025091914021034600_kfaf085-B66","doi-asserted-by":"crossref","first-page":"153056","DOI":"10.1016\/j.tox.2021.153056","article-title":"The role of mouse and human peroxisome proliferator-activated receptor-alpha in modulating the hepatic effects of perfluorooctane sulfonate in mice","volume":"465","author":"Su","year":"2022","journal-title":"Toxicology"},{"key":"2025091914021034600_kfaf085-B67","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pharmtox.41.1.123","article-title":"Phenobarbital response elements of cytochrome P450 genes and nuclear receptors","volume":"41","author":"Sueyoshi","year":"2001","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2025091914021034600_kfaf085-B68","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.toxlet.2005.11.015","article-title":"Fluconazole-induced hepatic cytochrome P450 gene expression and enzymatic activities in rats and mice","volume":"164","author":"Sun","year":"2006","journal-title":"Toxicol Lett"},{"key":"2025091914021034600_kfaf085-B69","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol Pathol"},{"key":"2025091914021034600_kfaf085-B70","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.yrtph.2014.09.011","article-title":"Liver tumor formation in female rat induced by fluopyram is mediated by CAR\/PXR nuclear receptor activation","volume":"70","author":"Tinwell","year":"2014","journal-title":"Regul Toxicol Pharmacol"},{"key":"2025091914021034600_kfaf085-B71","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/j.addr.2010.08.006","article-title":"Regulation of drug-metabolizing enzymes by xenobiotic receptors: PXR and CAR","volume":"62","author":"Tolson","year":"2010","journal-title":"Adv Drug Deliv Rev"},{"key":"2025091914021034600_kfaf085-B72","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0163-7258(96)00067-8","article-title":"Phenobarbital mechanistic data and risk assessment: enzyme induction, enhanced cell proliferation, and tumor promotion","volume":"71","author":"Whysner","year":"1996","journal-title":"Pharmacol Ther"},{"key":"2025091914021034600_kfaf085-B73","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1177\/0192623315576005","article-title":"Scientific and regulatory policy committee (SRPC) review: interpretation and use of cell proliferation data in cancer risk assessment","volume":"43","author":"Wood","year":"2015","journal-title":"Toxicol Pathol"},{"key":"2025091914021034600_kfaf085-B74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/10408444.2021.1939654","article-title":"Critical evaluation of the human relevance of the mode of action for rodent liver tumor formation by activators of the constitutive androstane receptor (CAR)","volume":"51","author":"Yamada","year":"2021","journal-title":"Crit Rev Toxicol"},{"key":"2025091914021034600_kfaf085-B75","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.1158\/0008-5472.CAN-04-1459","article-title":"The orphan nuclear receptor constitutive active\/androstane receptor is essential for liver tumor promotion by phenobarbital in mice","volume":"64","author":"Yamamoto","year":"2004","journal-title":"Cancer Res"},{"key":"2025091914021034600_kfaf085-B76","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bcp.2009.08.008","article-title":"Constitutive androstane receptor transcriptionally activates human CYP1A1 and CYP1A2 genes through a common regulatory element in the 5'-flanking region","volume":"79","author":"Yoshinari","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"2025091914021034600_kfaf085-B77","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0006-2952(97)00476-0","article-title":"Effect of phenobarbital on hepatic CYP1A1 and CYP1A2 in the ahr-null mouse","volume":"55","author":"Zaher","year":"1998","journal-title":"Biochem Pharmacol"},{"key":"2025091914021034600_kfaf085-B78","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1126\/science.1073502","article-title":"Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR","volume":"298","author":"Zhang","year":"2002","journal-title":"Science"}],"container-title":["Toxicological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/toxsci\/advance-article-pdf\/doi\/10.1093\/toxsci\/kfaf085\/63477904\/kfaf085.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/207\/1\/238\/63477904\/kfaf085.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/toxsci\/article-pdf\/207\/1\/238\/63477904\/kfaf085.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T18:02:32Z","timestamp":1758304952000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/toxsci\/article\/207\/1\/238\/8160942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,12]]},"references-count":78,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6,12]]},"published-print":{"date-parts":[[2025,9,1]]}},"URL":"https:\/\/doi.org\/10.1093\/toxsci\/kfaf085","relation":{},"ISSN":["1096-6080","1096-0929"],"issn-type":[{"type":"print","value":"1096-6080"},{"type":"electronic","value":"1096-0929"}],"subject":[],"published-other":{"date-parts":[[2025,9]]},"published":{"date-parts":[[2025,6,12]]}}}